US Stock MarketDetailed Quotes

ImageneBio (IMA)

Watchlist
  • 4.850
  • -0.035-0.72%
Close Sep 4 16:00 ET
  • 4.850
  • 0.0000.00%
Post 16:10 ET
55.05MMarket Cap-1.03P/E (TTM)

About ImageneBio Company

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.

Company Profile

SymbolIMA
Company NameImageneBio
Listing DateMar 26, 2021
ISINUS45175G2075
Founded2016
CEODr. Kristin Yarema, PhD
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address12526 High Bluff Drive,Suite 345
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-617-901-7098

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Kristin Yarema, PhD
  • Director and Chief Executive Officer
  • 8.17M
  • Yanina Grant-Huerta
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Jonathan Jian Wang, M.B.A.,PhD
  • Chairman of the Board
  • 157.79K
  • Joseph P. Slattery, C.P.A.
  • Independent Director
  • 158.85K
  • Dr. Weiguo Su, Pd.D
  • Independent Director
  • 157.79K
  • Dr. Otello Stampacchia, PhD
  • Independent Director
  • 27.01K
  • Dr. David P. Bonita, M.D.
  • Lead Independent Director
  • 30.51K
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More